Abstract
during a secondary infection is largely unknown. Furthermore, because expression of CD62L is often used to identify the central memory (T CM ) CD8 + T cell subset, uncoupling the physical requirement for CD62L-mediated lymph node homing versus other functional attributes of T CM CD8 + T cells remains unresolved. Here, we show that in contrast to naïve CD8 + T cells, memory CD8 + T cells traffic into the skin independent of CD62L-mediated lymph node re-activation and provide robust protective immunity against Vaccinia virus (VacV) infection. T CM , but not effector memory (T EM ), CD8 + T cells differentiated into functional CD69+/CD103-tissue residents following viral clearance, which was also dependent on local recognition of antigen in the skin microenvironment. Finally, we found that memory CD8 + T cells expressed granzyme B after trafficking into the skin and utilized cytolysis to provide protective immunity against VacV infection. Collectively, these findings demonstrate that T CM CD8 + T cells become cytolytic following rapid infiltration of the skin to protect against viral infection and subsequently differentiate into functional CD69+ tissue-residents.
Author summary
Following vaccination or resolution of viral infection, three distinct populations of virusspecific memory CD8 + T cells are generated. Central memory cells (T CM ) circulate between blood and lymph nodes and are able to rapidly enter non-lymphoid tissues in response to infection or tissue injury. In contrast, effector memory (T EM ) are largely restricted to the blood and tissue-resident memory cells (T RM ) are primarily confined within non-lymphoid tissues. In this study, we set out to interrogate the functionality and a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
Introduction
Following acute infection or successful vaccination, antigen-specific CD8 + T cells that survive contraction differentiate into long-lived memory cells that provide protective immunity against re-infection. Memory CD8 + T cells exhibit a variety of functional characteristics (e.g.
production of cytokines, cytolytic activity) that allow them to provide protective immunity against viruses and other intracellular pathogens [1, 2] . Another key feature of memory CD8 + T cells is their acquired ability to infiltrate and/or be retained in non-lymphoid tissues, whereas naïve CD8 + T cells are largely restricted to the circulation and secondary lymphoid organs [3, 4] . Memory CD8 + T cells can be broadly classified as those that are present in the circulation and those that remain in non-lymphoid tissues, now referred to as "tissue-resident" memory cells (T RM ) [5] . Because of their location, often at environmental barriers, it is believed that pro-inflammatory T RM CD8 + T cells are the cells most responsible for immediate protection against re-infections [6] [7] [8] [9] [10] , prior to the trafficking of additional circulating memory CD8 + T cells into the site of infection to further promote pathogen clearance [11] . Understanding the mechanisms that control both the formation and protective features of these diverse memory T cell populations remains a challenge for rational vaccine design and development. Both T RM and memory CD8 + T cells in the circulation provide protective immunity against re-infections of the skin and other non-lymphoid tissues. Following T cell receptor (TCR) engagement, T RM CD8 + T cells rapidly produce IFNγ that initiates a local inflammatory response and also promotes a general "anti-viral" state in the tissue microenvironment [12, 13] . Alternatively, in response to inflammatory cues, circulating memory CD8 + T cells rapidly enter non-lymphoid tissues and also provide significant protective immunity against viral skin infection [14, 15] . Memory CD8 + T cells in the circulation are often classified as being either central (T CM ) or effector (T EM ) memory based on the expression of receptors required for lymph node homing (i.e. CD62L and CCR7) [16] . We have recently demonstrated that T CM CD8 + T cells are the primary memory cell subset that rapidly infiltrates the skin following
VacV infection, whereas T EM CD8 + T cells are mostly confined to the circulation [15] . Because CD62L is often used to identify the T CM subset in mice, uncoupling the physical requirement for CD62L-mediated lymph node homing versus other functional attributes of T CM CD8 + T cells during a secondary challenge has, for the most part, been correlative. Furthermore, the protective mechanisms used by circulating memory CD8 + T cells to control viral infection after trafficking into the skin are largely undefined. The role that the tissue microenvironment plays in regulating the differentiation of T RM CD8 + T cells remains controversial. In contrast to systemic viral infections such as lymphocytic choriomeningitis virus (LCMV), infection of the skin with herpes simplex virus-1 (HSV-1) or Vaccinia virus (VacV) activates naïve antigen-specific CD8 + T cells that subsequently traffic into and differentiate into T RM almost exclusively at the site of infection [17] [18] [19] , suggesting that local inflammation, at least in part, is critical for promoting the acquisition of the T RM phenotype. Tissue-resident memory CD8 + T cells are often identified by expression or co-expression of CD69 and CD103 (α E integrin) and both of these proteins contribute to the formation of T RM in the skin [20, 21] . When paired with β 7 integrin, CD103 becomes a receptor for E-cadherin and it has been proposed that this interaction is critical for retaining CD8 + T cells in the epidermis. An analysis of skin from healthy human subjects agrees with this model, as CD103-expressing CD8 + T cells are enriched in the epidermis compared to the cells that only express CD69 [22] . TGFβ-receptor signaling causes effector CD8 + T cells to express CD103, suggesting that the capacity to respond to TGF-β may be an important retention signal that facilitates T RM differentiation in the skin and other E-cadherin-rich non-lymphoid tissues [20, 23] . In contrast, overexpression of genes that promote tissue egress including the transcription factor KLF2 or the sphingosine-1-phosphate receptor (S1P 1 ; S1PR1) antagonizes T RM development [24] . Collectively, these findings suggest that within tissue microenvironments, the ultimate fate of activated CD8 + T cells is highly dependent on the integration of conflicting signals that either promote or inhibit non-lymphoid tissue recruitment and retention. However, the signaling mechanisms within the tissue microenvironment and the cellular origins of either the CD69+ or CD69+/CD103+ T RM subsets in the skin remain largely undefined.
In this study, we analyzed the functionality and lineage relationship of memory CD8 + T cell populations following a secondary viral skin infection. We found that circulating memory CD8 + T cells rapidly traffic into the skin following VacV infection independent of their ability to survey peripheral lymph nodes and provide significant protective immunity. In contrast to naïve CD8 + T cells, most circulating T CM CD8 + T cells do not express CD103 in the skin microenvironment during the resolution of viral infection and only a subset ultimately became functional CD69+/CD103-T RM . Finally, after entering VacV-infected skin, circulating memory CD8 + T cells expressed granzyme B and required cytolytic function to provide protection against VacV infection. Altogether, this study demonstrates that T CM CD8 + T cells will rapidly infiltrate non-lymphoid tissues in response to local inflammatory cues, accelerate viral clearance, and become secondary CD69+ T RM that form following the resolution of viral skin infection, an important consideration for tissue-specific vaccine development.
Results

Circulating memory CD8 + T cells rapidly traffic into the skin and provide protective immunity against viral skin infection
Acute, systemic infection with LCMV-Armstrong causes antigen-specific T RM CD8 + T cells to be seeded in a variety of non-lymphoid tissues (e.g. lung, gut, female reproductive tract) [23] .
To determine if acute LCMV infection would also generate T RM CD8 + T cells in the skin, naive P14 TCR-transgenic CD8 + T cells specific for LCMV GP [33] [34] [35] [36] [37] [38] [39] [40] [41] were transferred into naïve B6 mice and infected with either LCMV by intraperitoneal (i.p.) injection or VacV expressing GP [33] [34] [35] [36] [37] [38] [39] [40] [41] (VacV-GP33) by skin scarification. At 40 days post-infection, the distribution of memory P14 CD8 + T cells was analyzed in the skin, circulation, and lymphoid tissues (S1A and
S1B Fig).
As we have shown previously, infection of the skin with VacV generated both circulating memory CD8 + T cells as well as T RM in the previously infected skin. In contrast, limited numbers of memory P14 CD8 + T cells could be isolated from the skin of mice infected with LCMV and these cells did not express the canonical T RM markers CD69 or CD103 (S1C and CD62L-Independent Function of T CM CD8 + T cells
S1D Fig).
Thus, acute LCMV infection generates circulating memory CD8 + T cells, but does not generate T RM CD8 + T cells in the skin.
Because LCMV infection did not seed T RM into the skin, we used the strategy of infecting LCMV-immune mice with VacV-GP33 to specifically monitor the antigen-specific memory CD8 + T cell recall response against viral skin infection. As we have shown previously [14, 15] , circulating memory CD8 + T cells rapidly infiltrated the VacV-infected skin by day 3 postinfection, which was further increased by another~10 fold on day 7 (Fig 1A) . On day 3 postinfection, memory P14 CD8 + T cells had proliferated in the draining lymph node, but the majority of the cells that trafficked into VacV-infected skin had not proliferated and were CD127+/KLRG1- (Fig 1B-1E) , suggesting that memory CD8 + T cells initially trafficked into the skin directly from the circulation and were not "re-primed" in the draining lymph node prior to infiltrating the skin microenvironment. In contrast, on day 7 post-infection, a variety of different populations of effector/memory CD8 + T cells were detected in the skin (based on expression of CD127 and KLRG1) and nearly all of the cells had proliferated. Antigen-specific memory CD8 + T cells reduced VacV burden in the skin as early as day 3 post-infection and began clearing the infection approximately 5 days earlier compared to naïve controls (Fig 1F) . Thus, these data agree with the model that circulating memory CD8 + T cells respond to re- CD62L-Independent Function of T CM CD8 + T cells challenge to provide protective immunity in two phases [11] . Initially, memory CD8 + T cells directly infiltrate inflamed, non-lymphoid tissues to immediately control infection, which is followed by the subsequent recruitment of effector/memory CD8 + T cells that were re-activated in the draining lymph node.
Circulating memory CD8 + T cells traffic into VacV-infected skin in a CD62L-independent fashion and become CD69+ after viral clearance CD62L is required for naïve T cells to adhere to and traffic across high endothelial venules and into peripheral lymph nodes [25, 26] (Fig 2A and 2B ).
An extended longitudinal analysis of blood demonstrated that CD62L was necessary for antigenspecific naïve CD8 + T cell activation and expansion following VacV-GP33 skin infection, but was not required for the expansion, contraction and establishment of circulating antigen-specific memory CD8 + T cells following systemic LCMV infection (Fig 2C-2F) . Thus, the capacity to traffic into lymph nodes is necessary for naïve CD8 + T cells to become activated during a peripheral skin infection, but is not required for their activation during systemic viral infection. Because we found that naïve CD62L -/-CD8 + T cells were activated following systemic LCMV infection, we next evaluated whether they became functional circulating memory cells. 
CD62L-Independent Function of T CM CD8 + T cells
At 50 days post LCMV infection, CD62L was expressed on~50% of circulating WT memory CD8 + T cells (Fig 3A) . Both WT and CD62L -/-memory P14 CD8 + T cells were largely CD127
+/CD27+/KLRG1-and produced IFNγ following stimulation with GP [33] [34] [35] [36] [37] [38] [39] [40] [41] peptide. (S2A- S2F  Fig) . As predicted [27] , there were fewer CD62L -/-memory CD8 + T cells in lymph nodes compared to WT controls, but similar numbers were found in the spleen (Fig 3B-3D ). Because 
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+ T cells CD62L -/-memory CD8 + T cells that formed after LCMV infection were functional, we next tested whether CD62L-mediated lymph node surveillance was also required for memory CD8 + T cells to respond to viral skin infection. Both WT and CD62L -/-memory CD8 + T cells synthesized ligands for P-and E-selectin following stimulation with IL-15 (Fig 3E) , which we have previously demonstrated to be essential for memory CD8 + T cell trafficking into the skin following viral infection [14] . Indeed, CD62L -/-memory CD8 + T cells rapidly trafficked into the skin following VacV-GP33 infection similar to WT cells (Fig 3F) , even though secondary expansion of CD62L -/-memory CD8 + T cells in the circulation was significantly diminished (Fig 3G) . Nevertheless, similar numbers of both WT and CD62L -/-memory P14 CD8 + T cells remained in the skin on day 40 following the resolution of VacV infection (Fig 3H) . These data demonstrate that lymph node surveillance mediated by CD62L is required for naïve CD8 + T cells to become activated following a primary VacV infection of the skin, but not for memory CD8 + T cells to rapidly infiltrate and accumulate in the skin during a secondary viral infection.
We and others have shown that following activation, naïve antigen-specific CD8 + T cells differentiate into largely CD69+/CD103+ T RM after the resolution of VacV skin infection. In contrast, most memory CD8 + T cells isolated from the skin at day 40 post VacV infection did not express CD103 and only a subset expressed CD69 (Fig 3I and 3J ). CD69+ memory P14 CD8 + T cells in the skin also expressed higher levels of core 2 O-glycans (required for synthesis of P-and E-selectin ligands [28] ) and CD44, whereas both the CD69+ and CD69-subsets expressed low levels of CD122 compared to memory CD8 + T cells in the spleen (S3A-S3E Collectively, these data suggest that circulating memory CD8 + T cells traffic directly into the skin in a CD62L-independent manner to provide protective immunity against viral infection, but are limited in their capacity to differentiate into canonical CD103+/CD69+ T RM CD8 + T cells.
CD69+ memory CD8 + T cells that form in the skin following secondary challenge are tissue-resident
Intravenous labeling with fluorescent antibody is often used to distinguish between immune cells in the circulation and those residing in non-lymphoid tissues such as the skin [29] . To first evaluate whether the memory CD8 + T cells in the skin were re-circulating or could potentially be tissue-resident, we again infected LCMV-immune mice with VacV-GP33 and on day 40 post-infection, delivered anti-CD8β antibody by intravenous injection for 3 minutes prior to isolating memory P14 CD8 + T cells from the skin and blood (S4A analysis revealed that~30-50% of the CD69-memory CD8 + T cells the skin were labeled with the antibody, but most of the CD69+ subset was protected (S4B and S4C Fig) . These data suggest that the CD69-memory CD8 + T cells isolated from the skin were likely a re-circulating population, whereas the CD69+ subset was confined to the skin microenvironment.
To further confirm that the CD69+ memory CD8 + T cells were resident, we next utilized a Thy1.1 depleting antibody, which eliminates Thy1.1 expressing cells from the circulation, but not T RM in the skin [18] . Following administration, secondary memory CD8 + T cells were readily depleted from the circulation, but were largely, although not completely, protected in the skin (S5A- S5E Fig) . Similar to the result acquired by IV labeling, the memory P14 CD8 + T cells in the skin that were eliminated by the Thy1.1 depleting antibody were mostly the CD69-/ CD62L-Independent Function of T CM CD8 + T cells CD103-subset (Fig 4A-4D) , whereas cells that expressed CD69 (both CD103+/-) were protected, suggesting that memory CD8 + T cells that expressed CD69 in the skin following clearance of a secondary viral infection were resident in the non-lymphoid tissue. Following TCR stimulation, antigen-specific T RM CD8 + T cells that form following a primary infection rapidly express IFNγ and mediate local inflammation in the tissue microenvironment [12, 13, 18] . To determine whether the CD69+ cells in the skin that formed from circulating memory CD8 + T cells would also cause antigen-specific inflammation and/or produce IFNγ in vivo, we generated YFP-IFNγ reporter P14 CD8 + T cells [30] . Mice harboring T RM that formed from circulating memory YFP-IFNγ P14 CD8 + T cells were challenged with GP 33-41 peptide or control peptide and expression of YFP was analyzed 6 hours later. Topical challenge with antigenic peptide, but not control peptide, caused CD69+ P14 CD8 + T cells in the skin to produce IFNγ (Fig 4E) . Although the frequency of CD69+ memory CD8 + T cells in the skin did not change following peptide challenge, IFNγ expression was found exclusively in the CD69+ subset (Fig 4F and 4G) . Finally, GP [33] [34] [35] [36] [37] [38] [39] [40] [41] peptide challenge also caused tissue swelling (Fig 4H) , suggesting that the T RM derived from circulating memory CD8 + T cells were positioned to rapidly respond to antigens in the periphery and initiate local inflammatory responses. Collectively, these data suggest that the CD69+ P14 CD8 + T cells that formed from circulating memory CD8 + T cells exhibit functional features of bona fide T RM CD8 + T cells. 
Circulating memory CD8 + T cells differentiate into CD69+ T RM in an antigen-specific manner
Previously, we have demonstrated that local antigen recognition in the skin significantly increases the generation of antigen-specific T RM CD8 + T cells following a primary VacV infection [18] . To determine whether memory CD8 + T cells that traffic directly into VacV-infected skin also relied on local antigen recognition to become a CD69+ T RM , we co-infected LCMVimmune mice with VacV-GP33 on the left ear skin and VacV expressing the model antigen OVA 257-264 (VacV-OVA) on the right, as these viral infections are restricted to the skin microenvironment and do not become systemic [18] . Notably, using this strategy, we have also previously shown that GP33-specfic memory CD8 + T cells in LCMV-immune animals provide protective immunity in the VacV-GP33 infected skin, but not the VacV-OVA infected skin [15] . On day15 post-infection, memory P14 CD8 + T cells had trafficked into the skin of both viral infections (Fig 5A) , but expressed more CD69 when cognate antigen was present in the VacV-infected skin microenvironment (Fig 5B and 5C) . Furthermore, on day 40 postinfection, more CD69+ memory P14 CD8 + T cells were present in the skin infected with
VacV-GP33 compared to the skin infected with VacV-OVA (Fig 5D) , demonstrating that local antigen recognition in the skin increased the retention of antigen-specific secondary T RM CD8 + T cells. Collectively, these data show that like naïve CD8 + T cells, circulating memory CD8 + T cells become CD69+ T RM primarily at the site of viral infection in an antigen-specific manner.
CD69+ T RM cells that form following secondary viral skin infection are derived from reactivated T CM CD8 + T cells
Memory CD8 + T cells in the circulation can be broadly defined as being either T EM or T CM by the expression of receptors required for lymph node trafficking across high endothelial venules [31, 32] . To determine which of these subsets differentiated into CD69+ T RM that formed in the skin, we sorted T CM and T EM P14 CD8 + T cells based on expression of CD62L and transferred equal numbers into naïve mice followed by infection with VacV-GP33 (Fig 6A) . T CM expanded and trafficked into the skin better than T EM CD8 + T cells throughout the course of the VacV infection (Fig 6B and 6C) . Reactivated T CM CD8 + T cells expressed slightly more CD69 in the skin than T EM CD8 + T cells, whereas both subsets expressed equally low levels of 
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+ T cells CD103 (Fig 6D and 6E) . By day 40 post-infection, a stable population of P14 CD8 + T cells that originated from T CM formed in the skin, whereas the transferred T EM CD8 + T cells were essentially undetectable (Fig 6F) . In contrast to T RM derived from naïve CD8 + T cells, T CM -derived T RM CD8 + T cells were also largely CD69+/CD103- (Fig 6G) . Overall, these data, along with our previous study [15] demonstrate that circulating T CM are both the major tissue-trafficking memory CD8 + T cells subset and become CD69+ T RM in the skin following reactivation.
Naïve CD8 + T cells express CD103 and become tissue-residents better than circulating T CM following viral skin infection
Because the previous experiment demonstrated that T CM became the CD69+ T RM that formed in the skin during secondary viral infection, we next tested whether T CM or naïve CD8 + T cells with VacV-GP33 (Fig 7A and 7B) . Both CD8 + T cell populations trafficked into the skin on day 15 post-infection and previously naïve CD8 + T cells began expressing CD103 and CD69
[18], but T CM CD8 + T cells in the same skin microenvironment expressed only CD69 (Fig 7C-7E ). In addition, previously naïve P14 CD8 + T cells were found at increased frequencies compared to T CM in the infected skin microenvironment on days 15 and 40 post VacV infection (Fig 7F) , but both populations were equally represented in the spleen, demonstrating that the (Fig 7G) . Overall, these data reveal that on a per cell basis, naïve CD8 + T cells express more CD103 after infiltrating the VacV infected skin and more efficiently become mature T RM compared to T CM CD8 + T cells.
TGF-β is a known stimulator of CD103 expression and both TGFβRII -/-and CD103
-/-CD8 + T cells exhibit reduced T RM differentiation during viral infection of the skin [20] .
Because most T CM did not express CD103 in the skin following VacV skin infection, we next assessed whether this was due to limited capacity to express this integrin downstream of TGF-β receptor signaling. On day 10 post-infection, previously naïve, T CM , and T EM P14 CD8 + T cells from the spleen were stimulated ex vivo with increasing concentrations of TGF-β1. In agreement with our data from Fig 7C and 7D ,~60% of previously naïve CD8 + T cells expressed CD103 when stimulated with TGF-β (Fig 8A and 8B) . In contrast, only~25% of T CM and T EM CD8 + T cells expressed CD103 following TGF-β stimulation. This result was not specific to VacV skin infection, as both T CM and T EM CD8 + T cells reactivated by systemic LCMV infection also exhibited reduced TGF-β-stimulated CD103 expression compared to previously naïve CD8 + T cells (S6A and S6B Fig) . Thus, these data suggest that TGF-β-mediated CD103 expression is largely a feature of previously naïve CD8 + T cells that become activated following infection. (Fig 9A and 9B) , but provided less protection against the virus (Fig 9C) . In agreement with Fig 3, CD62L -/-OVA-specific CD8 + T cells in LM-OVA immune mice expanded less than WT controls following VacV-OVA challenge (Fig 9D and 9E) , but still provided protective immunity against viral skin infection (Fig 9F) . This result was not specific to OVA-specific memory CD8 + T cells or vaccination with attenuated Listeria, as CD62L -/-GP33-specific circulating memory CD8 + T cells that formed following LCMV infection also provided protective immunity against VacV-GP33 infection of the skin similar to WT controls (S7B- S7E Fig) .
CD62L-Independent Function of T CM CD8 + T cells
Circulating memory CD8 + T cells use cytolysis to provide protective immunity against VacV skin infection
Collectively, these data demonstrate that circulating memory CD8 + T cells require perforin, but not CD62L-mediated lymph node surveillance to provide protective immunity in the skin.
Discussion
T RM CD8 + T cells are believed to play an important role in host defense against pathogens, but have also been suggested to be the dysfunctional culprit in a variety of inflammatory diseases of the skin and perhaps other non-lymphoid tissues [36, 37] . Thus, an understanding of both the cell intrinsic mechanisms, as well as the cell extrinsic microenvironment inflammatory 
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+ T cells factors that ultimately control the formation of these cell populations is highly relevant for a variety of diseases and pathological conditions. Most studies to date have focused on the capacity for T RM CD8 + T cells to develop from naïve CD8 + T cells following a primary infection in mice, where no protective adaptive immunity against the pathogen is present. Notably, there are essentially no T RM CD8 + T cells in laboratory mice prior to any type of experimental manipulation, whereas human skin is rich in a heterogeneous mixture of CD8 + and CD4 + T cells exhibiting a variety of phenotypes [22] . This observation suggests that exposure to environmental antigens and pathogens throughout life is continually shaping the composition of the skin T cell repertoire [38] . Because most of our current knowledge of the mechanisms controlling T RM formation have been studied in the context of a primary infection, understanding how pre-existing immunological memory and dynamic host-pathogen interactions within the local tissue microenvironment impact T RM differentiation has remained largely unknown. 
CD62L-Independent Function of T CM CD8 + T cells
Recent studies by us and others suggest that antigen recognition in non-lymphoid tissues such as the skin and lung will significantly increase the formation of T RM following a primary infection [18, [39] [40] [41] [42] . Indeed, we also found that memory CD8 + T cells became enriched in the skin microenvironment where antigen recognition occurred during a secondary challenge. Interestingly, however, we also found that most circulating memory CD8 + T cells that infiltrate the skin during VacV infection express CD69 following antigen recognition, but are unable to express CD103 when stimulated with TGF-β. Although the generation of a local inflammatory environment is clearly essential for T cell recruitment prior to T RM differentiation, it has also been demonstrated that antigen recognition and some pro-inflammatory cytokines such as IL-12 and IFNβ will inhibit CD103 expression [23, 43] . In contrast to our findings, it has recently been reported that CD69+/CD103+ T RM CD8 + T cells are generated from circulating memory CD8 + T cells following HSV-1 skin infection [44] . Interestingly, we and others have shown that local antigen recognition in the skin is critical for T RM CD8 + T cells to form following poxvirus infection [18, 39, 45] , whereas antigen-specific T RM formation does not seem to occur during skin infection with HSV-1 [9] . Because here we also show that CD69+ T RM are generated by circulating memory T cells in an antigen-specific manner, this suggests that antigen recognition in the skin is critical for the formation of this population following poxvirus infection, but may not form and/or be retained during HSV-1 skin infection. Thus, it seems that both antigen recognition and the cytokine milieu within the tissue microenvironment act in concert to ultimately control the extent of T RM differentiation, but how these diverse signaling pathways are integrated in vivo is still largely undefined. Nevertheless, our data support a model where expression of CD69 identifies skin T RM that received a local antigen recognition event, but not a TGF-β (or perhaps additional cytokines) signal to transition into a CD103 +/CD69+ T RM . Our study also highlights that the capacity for memory CD8 + T cells to home into and survey peripheral lymph nodes does not play a major role during a secondary recall response against a local skin infection and that the primary feature of T CM that allows this memory subset to provide protective immunity is their capacity to rapidly and specifically traffic into inflamed non-lymphoid tissues. Another recent report demonstrated that KLRG1+, CX3CR1 + T EM CD8 + T cells are essentially confined to the circulation and are unable to infiltrate nonlymphoid tissues during steady-state homeostatic trafficking [46] . In addition, it has also been recently reported that T CM CD8 + and CD4 + T cells from humans express significant levels of non-lymphoid tissue-homing addressins and induce skin inflammation in a mouse model of dermatitis [47] . These studies agree with our data demonstrating that T CM are the major tissue trafficking subset that provides protection against VacV skin infection [15] and also are precursors to CD69+ T RM . In contrast, highly cytolytic T EM CD8 + T cells provide more protective immunity than T CM against systemic infections that reach the circulation and/or spleen (i.e., when pathogens are delivered to mice intravenously or into the peritoneal cavity) [48, 49] . Interestingly, we found that circulating memory CD8 + T cells also require cytolysis to control
VacV infection of the skin and limit inflammation, which is in contrast to T RM CD8 + T cells, which have been proposed to provide their protective benefit through local production of IFNγ [12, 13] . It will be of interest to determine whether circulating memory CD8 + T cells use cytolysis as the primary mechanism to control other intracellular pathogens in non-lymphoid tissues or if the production of cytokines (e.g. IFNγ, TNFα) is required to protect against some types of infections. Altogether, our findings suggest that the circulating T CM CD8 + T cells function as the first responders against infections in peripheral tissues, ultimately controlling and eliminating viral infection. In summary, our results demonstrate that T CM CD8 + T cells traffic into non-lymphoid tissue microenvironments following viral infection in a CD62L-independent fashion and protect
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against poxvirus using perforin-mediated cytotoxicity. Our finding that the majority of the memory CD8 + T cells initially recruited into the site of viral infection (by day 3) had not proliferated strongly suggests that the primary feature of T CM that allows this memory subset to provide rapid protective immunity is their ability to infiltrate inflamed non-lymphoid tissues, rather than the re-activation/proliferative expansion in draining lymph nodes. In fact, recent experimental evidence suggests that terminally differentiated T EM CD8 + T cells are largely confined to the circulation and not actively surveying non-lymphoid tissues [15, 46, 50] and thus, the long-standing model describing the trafficking potentials of T CM and T EM CD8 + T cells subsets continues to be refined. Overall, our findings provide new insight regarding the protective mechanisms used by circulating memory CD8 + T cells during a secondary viral infection in peripheral tissues, but also reveals important information about how "prime-boost" vaccination strategies of generating circulating memory CD8 + T cells followed by a local heterologous challenge will generate antigen-specific secondary memory T cell populations in nonlymphoid tissues such as the skin.
Materials and methods
Ethics statement
All animal experiments were conducted in accordance with the Animal Welfare Act and the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. Approved by the OHSU Institutional Animal Care and Use Committee (Protocol Number IP00715) and Institutional Biosafety Committee (Registration Number IBC-13-33).
Mice and pathogens
C57BL/6N mice were purchased from NCI/Charles River. Perforin -/- [51] and IFN-γ YFP reporter [30] mice were purchased from Jackson Laboratories. P14 TCR-transgenic [52] and Lsel -/- [26] mice have been previously described and were maintained by sibling x sibling mat- 
Quantification of VacV from infected skin
Quantification of viral load in the infected skin was determined using standard plaque assays on BSC-40 cells. Briefly, infected ears were removed and homogenized in 1 ml of RPMI supplemented with 1% fetal bovine serum. Skin homogenates were then subjected to three rounds of freeze-thaw before serial dilutions were inoculated on BSC-40 cells in a 12-well plate that were then covered with 1% Seakem agarose in Modified Eagle Medium (Gibco). Plaques were visualized three days later following overnight incubation with Neutral Red dye.
Leukocyte isolation from skin
Ears from infected mice were removed and the dorsal and ventral sides of the ear pinna were separated and allowed to incubate for 1-2 hours at 37˚C with 1-2 ml HBSS (Gibco) containing CaCl 2 and MgCl 2 supplemented with 125 U/ml collagenase (Invitrogen) and 60 U/ml DNase-I (Sigma-Aldrich) at 37˚C. Whole tissue suspensions were then generated by gently forcing the tissue through a wire mesh screen. Leukocytes were then purified from whole tissue suspensions by re-suspending the cells in 10 mL of 35% Percoll (GE Healthcare)/HBSS in 50 mL conical tubes followed by centrifugation (500 x g) for 10 minutes at room temp. To identify tissueresident CD8 + T cells by intravenous labeling, Anti-CD8β antibody (clone YTS156.7.7, 3 μg)
was diluted in 200 μl of PBS and delivered to mice via intravenous injection. After 3 minutes, mice were immediately sacrificed and cells from the skin were isolated as described above. 
Flow cytometry and cell sorting
Antibodies
The following antibodies for flow cytometry and corresponding isotype controls were used in this study: CD8α (53-6.7, BioLegend), CD44 (1M7, BioLegend), CD45.2 (104, Tonbo), CD62L (MEL-14, BioLegend), Thy1.1 (OX-7, BioLegend), Thy1.2 (53-2.1, BioLegend), CD69 (H1.2F3, BioLegend), CD103 (2E7, BioLegend), CD127 (A7R34, BioLegend), KLRG1 (2F1, Tonbo), BrdU (3D4, BioLegend), Vα2 TCR (B20.1, BioLegend), IFNγ (XMG1.2, Tonbo), CD122 (5H4, BioLegend), glycosylated isoform of CD43 (1B11, BioLegend), CD107a (1D4B, BioLegend), CD107b (M384, BioLegend), CD27 (LG.3A10, BioLegend), granzyme B (GB11, BioLegend).
Synthesis of P-and E-selectin ligands
To detect synthesis of P-and E-selectin ligands, WT and CD62L -/-memory P14 CD8 + T cells from spleens were stimulated for 3 days with 250 ng/ml of recombinant mouse IL-15 (Peprotech). Recombinant E-selectin (5 μg/ml) and P-selectin (1.5 μg/ml) human IgG Fc chimeric proteins (R & D Systems) were incubated with cells for 30 minutes in 1% FBS/DPBS containing Ca 2+ and Mg 2+ (Gibco) at room temperature. Binding of selectins was detected using antihuman IgG-Fc PE (eBioscience). Cells were then stained with fluorescent antibodies as described in Flow Cytometry and Antibodies.
Ex vivo peptide and TGF-β stimulation
Spleens were collected on the indicated days post-VacV infection and single cell suspensions were generated by gently forcing the tissue through a mesh screen. For detection of IFNγ, 
In vivo peptide challenge
GP [33] [34] [35] [36] [37] [38] [39] [40] [41] or NP 396-404 peptides (5 μg) were dissolved in 20 μL of 4:1 acetone/DMSO. Mice were anesthetized with isofluorane and the dissolved peptide solution was applied to both the dorsal and ventral sides of previously infected ear skin. Tissue swelling and IFNγ expression was analyzed 6 hours after challenge. Thickness of the ear pinna was measured on anesthetized mice with a dial micrometer (Ames).
BrdU incorporation
LCMV-immune B6 mice were administered 2 mg of Brdu (Sigma) in PBS one day prior to VacV infection and provided drinking water containing 0.8 mg/ml during the 7 day course of infection. Staining of cells for BrdU incorporation was performed using the BrdU Flow kit (BD Bioscienes) according to the manufacturers protocol. Briefly, single cell suspensions of leukocytes were generated from the skin and spleen as described previously. 
Statistical analysis
Statistical analyses were performed with Prism software (version 6.0, GraphPad Software) using either the paired or unpaired Student's t test or ANOVA with Tukey's post-test for significance. 
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